REPAGLINIDE 0.5 MG TABLET

Repaglinide
$0.0812per EA

Strength

.5 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135094690

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

REPAGLINIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078555

On Market Since

11/22/2013

Pharmacological Classes

Glinide
Potassium Channel Antagonists

Price History

1W

0.0%

1M

+0.7%

3M

+5.2%

6M

-8.8%

1Y

N/A

3Y

N/A

5Y

N/A

All

-8.5%